These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24080323)

  • 1. Personalized antiplatelet therapy: the wrong approach?
    Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2013 Oct; 106(10):481-6. PubMed ID: 24080323
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R; Rossini R; Musumeci G; Gadda F; Pozzo LF
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of antiplatelet therapy resistance in cardiac surgery.
    Gasparovic H; Petricevic M; Biocina B
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):855-62. PubMed ID: 24332669
    [No Abstract]   [Full Text] [Related]  

  • 4. High Platelet Reactivity and Intrastent Thrombi Assessed by OCT After DES.
    Fukuhara K; Okura H; Kume T; Yamada R; Neishi Y; Uemura S; Yoshida K
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):210-212. PubMed ID: 27085448
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet Reactivity: Is There a Role to Switch?
    Aradi D; Merkely B; Komócsi A
    Prog Cardiovasc Dis; 2015; 58(3):278-84. PubMed ID: 26260612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study.
    Siller-Matula JM; Francesconi M; Dechant C; Jilma B; Maurer G; Delle-Karth G; Gouya G; Ruzicka K; Podczeck-Schweighofer A; Christ G
    Int J Cardiol; 2013 Sep; 167(5):2018-23. PubMed ID: 22656044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
    Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.
    Mendolicchio GL; Zavalloni D; Bacci M; Roveda M; Quagliuolo V; Anselmi CV; Rota LL; Ruggeri ZM
    Thromb Haemost; 2015 Mar; 113(3):664-7. PubMed ID: 25428265
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.
    Lee HJ; Yu CW; Hwang HK; Choi RK; Park JS; Li H; Ro YM
    Coron Artery Dis; 2013 Nov; 24(7):542-8. PubMed ID: 23994880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A; Ferlini M; Rossini R; Musumeci G; Arici V; Bramucci E; Setacci C
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):681-3. PubMed ID: 25008060
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretreatment with P2Y12 inhibitors in non-ST-segment elevation acute coronary syndrome: Time to revise the guidelines?
    Cayla G; Collet JP; Silvain J; Montalescot G
    Arch Cardiovasc Dis; 2014 Jan; 107(1):1-3. PubMed ID: 24332911
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should all stent patients have prolonged dual antiplatelet therapy?
    Kirtane AJ; King SB
    JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
    Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy after percutaneous coronary intervention.
    Holmes DR
    Cerebrovasc Dis; 2006; 21 Suppl 1():25-34. PubMed ID: 16479099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.